Detalhe da pesquisa
1.
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Histopathology
; 84(5): 723-741, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012539
2.
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719547
3.
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 84(7): 1111-1129, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443320
4.
An update on the pathological classification of breast cancer.
Histopathology
; 82(1): 5-16, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482272
5.
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance.
Histopathology
; 80(3): 515-528, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605058
6.
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Histopathology
; 81(4): 511-519, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879836
7.
Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates.
Pathobiology
; 89(5): 263-277, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728576
8.
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
Br J Cancer
; 124(11): 1836-1842, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762723
9.
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer.
Mod Pathol
; 34(7): 1271-1281, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33526875
10.
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.
Histopathology
; 78(5): 759-771, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113154
11.
The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer.
Pathobiology
; 86(2-3): 77-82, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30347405
12.
Management of the axilla post-neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?
Breast J
; 27(4): 394-396, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527552
13.
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland.
Curr Oncol
; 31(3): 1302-1310, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534931
14.
High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography.
Breast J
; 19(3): 319-24, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23600490
15.
Apocrine lesions of the breast.
Virchows Arch
; 480(1): 177-189, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537861
16.
Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting.
Arch Pathol Lab Med
; 146(11): 1308-1318, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270029
17.
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis.
Cancers (Basel)
; 13(22)2021 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830849
18.
The Extent of Axillary Lymph Node Clearance Required Following Detection of Sentinel Node Micrometastases.
Breast J
; 16(5): 533-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20626393
19.
Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma.
Virchows Arch
; 476(3): 367-372, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375912
20.
The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
Ann Surg
; 249(5): 834-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19387317